Xu, Qianqian <br/><br/>
TTK is a favorable prognostic biomarker for triple-negative breast cancer survival.  [electronic resource] 

 -  Oncotarget  Dec 2016 
 - 81815-81829 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.13245  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--analysis<br/>Cell Cycle Proteins--analysis<br/>Chi-Square Distribution<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Protein Serine-Threonine Kinases--analysis<br/>Protein-Tyrosine Kinases--analysis<br/>ROC Curve<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Triple Negative Breast Neoplasms--enzymology<br/>Up-Regulation<br/>Young Adult